Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

敌手 激活剂(遗传学) 生物合成 化学 药理学 细胞生物学 受体拮抗剂 生物化学 受体 白三烯 脂质信号 调解人 G蛋白偶联受体 脂氧合酶 生物 酶 二十烷酸 炎症 细胞培养 酶激活剂 白细胞介素1受体拮抗剂
作者
Christian Kretzer,Paul M Jordan,Rossella Bilancia,Antonietta Rossi,Tuğçe Gür Maz,Erden Banoğlu,Ulrich S. Schubert,Oliver Werz
出处
期刊:Journal of Inflammation Research [Dove Medical Press]
卷期号:Volume 15: 911-925 被引量:34
标识
DOI:10.2147/jir.s345510
摘要

BACKGROUND AND PURPOSE: Lipid mediators (LM) play crucial roles in the complex inflammation process with respect to initiation, maintenance, and resolution. Proinflammatory leukotrienes (LTs), generated by 5-lipoxygenase (LOX) and the 5-LOX-activating protein (FLAP), initiate and maintain inflammation while specialized pro-resolving mediators (SPMs) formed by various LOXs as key enzymes promote inflammation resolution and the return to homeostasis. Since 5-LOX also contributes to SPM biosynthesis, smart pharmacological manipulation of the 5-LOX pathway and accompanied activation of 12-/15-LOXs may accomplish suppression of LT formation but maintain or even elevate SPM formation. Here, we demonstrated that the FLAP antagonist BRP-201 possesses such pharmacological profile and causes a switch from LT toward SPM formation. METHODS AND RESULTS: Comprehensive LM metabololipidomics with activated human monocyte-derived macrophages (MDM) of M1 or M2 phenotype showed that BRP-201 strongly inhibits LT formation induced by bacterial exotoxins. In parallel, SPM levels and 12/15-LOX-derived products were markedly elevated, in particular in M2-MDM. Intriguingly, in unstimulated MDM, BRP-201 induced formation of 12/15-LOX products including SPM and caused 15-LOX-1 subcellular redistribution without affecting 5-LOX. Experiments with HEK293 cells stably expressing either 5-LOX with or without FLAP, 15-LOX-1 or 15-LOX-2 confirmed suppression of 5-LOX product formation due to FLAP antagonism by BRP-201 but activated 15-LOX-1 in the absence of FLAP. Finally, in zymosan-induced murine peritonitis, BRP-201 (2 mg/kg, ip) lowered LT levels but elevated 12/15-LOX products including SPMs. CONCLUSION: BRP-201 acts as FLAP antagonist but also as 12/15-LOX activator switching formation of pro-inflammatory LTs toward inflammation-resolving SPM, which reflects a beneficial pharmacological profile for intervention in inflammation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI65的应助被Code_king采纳,获得10
刚刚
华无剑的应助被Code_king采纳,获得10
刚刚
Claire完成签到 ,获得积分10
刚刚
ygtqcty发布了新的文献求助10
刚刚
jiafang完成签到,获得积分0
刚刚
guojiyao完成签到,获得积分10
1秒前
1秒前
七七完成签到 ,获得积分10
1秒前
小二郎的应助被迅速的伟帮采纳,获得10
1秒前
2秒前
xeq发布了新的文献求助10
2秒前
Huangzhisong发布了新的文献求助10
2秒前
2秒前
Ari发布了新的文献求助10
3秒前
超帅的保温杯完成签到 ,获得积分10
3秒前
3秒前
3秒前
共享精神的应助被菠萝采纳,获得10
3秒前
redmouse完成签到,获得积分10
4秒前
木木完成签到 ,获得积分10
4秒前
5秒前
5秒前
6秒前
6秒前
kailanshi发布了新的文献求助10
6秒前
lilili的应助被科研通管家采纳,获得10
6秒前
7秒前
英姑的应助被科研通管家采纳,获得10
7秒前
Hello的应助被科研通管家采纳,获得10
7秒前
jin的应助被科研通管家采纳,获得20
7秒前
7秒前
天天快乐的应助被科研通管家采纳,获得10
7秒前
7秒前
李健的应助被科研通管家采纳,获得10
7秒前
ccq的应助被科研通管家采纳,获得10
7秒前
wanci的应助被科研通管家采纳,获得10
7秒前
lilili的应助被科研通管家采纳,获得10
8秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
8秒前
8秒前
丘比特的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177654
求助须知:如何正确求助?哪些是违规求助? 9568503
关于积分的说明 21799551
捐赠科研通 7772253
什么是DOI,文献DOI怎么找? 3432428
关于科研通互助平台的介绍 2556594
邀请新用户注册赠送积分活动 2478011